Association of delayed adequate antimicrobial treatment and organ dysfunction in pediatric bloodstream infections.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
16 Oct 2023
16 Oct 2023
Historique:
received:
27
05
2022
accepted:
02
09
2023
revised:
13
06
2023
medline:
17
10
2023
pubmed:
17
10
2023
entrez:
16
10
2023
Statut:
aheadofprint
Résumé
Bloodstream infections (BSIs) are associated with significant mortality and morbidity, including multiple organ dysfunction. We explored if delayed adequate antimicrobial treatment for children with BSIs is associated with change in organ dysfunction as measured by PELOD-2 scores. We conducted a multicenter, retrospective cohort study of critically ill children <18 years old with BSIs. The primary outcome was change in PELOD-2 score between days 1 (index blood culture) and 5. The exposure variable was delayed administration of adequate antimicrobial therapy by ≥3 h from blood culture collection. We compared PELOD-2 score changes between those who received early and delayed treatment. Among 202 children, the median (interquartile range) time to adequate antimicrobial therapy was 7 (0.8-20.1) hours; 124 (61%) received delayed antimicrobial therapy. Patients who received early and delayed treatment had similar baseline characteristics. There was no significant difference in PELOD-2 score changes from days 1 and 5 between groups (PELOD-2 score difference -0.07, 95% CI -0.92 to 0.79, p = 0.88). We did not find an association between delayed adequate antimicrobial therapy and PELOD-2 score changes between days 1 and 5 from detection of BSI. PELOD-2 score was not sensitive for clinical effects of delayed antimicrobial treatment. In critically ill children with bloodstream infections, there was no significant change in organ dysfunction as measured by PELOD-2 scores between patients who received adequate antimicrobial therapy within 3 h of their initial positive blood culture and those who started after 3 h. Higher PELOD-2 scores on day 1 were associated with larger differences in PELOD-2 scores between days 1 and 5 from index positive blood cultures. Further study is required to determine if PELOD-2 or alternative measures of organ dysfunction could be used as primary outcome measures in trials of antimicrobial interventions in pediatric critical care research.
Sections du résumé
BACKGROUND
BACKGROUND
Bloodstream infections (BSIs) are associated with significant mortality and morbidity, including multiple organ dysfunction. We explored if delayed adequate antimicrobial treatment for children with BSIs is associated with change in organ dysfunction as measured by PELOD-2 scores.
METHODS
METHODS
We conducted a multicenter, retrospective cohort study of critically ill children <18 years old with BSIs. The primary outcome was change in PELOD-2 score between days 1 (index blood culture) and 5. The exposure variable was delayed administration of adequate antimicrobial therapy by ≥3 h from blood culture collection. We compared PELOD-2 score changes between those who received early and delayed treatment.
RESULTS
RESULTS
Among 202 children, the median (interquartile range) time to adequate antimicrobial therapy was 7 (0.8-20.1) hours; 124 (61%) received delayed antimicrobial therapy. Patients who received early and delayed treatment had similar baseline characteristics. There was no significant difference in PELOD-2 score changes from days 1 and 5 between groups (PELOD-2 score difference -0.07, 95% CI -0.92 to 0.79, p = 0.88).
CONCLUSIONS
CONCLUSIONS
We did not find an association between delayed adequate antimicrobial therapy and PELOD-2 score changes between days 1 and 5 from detection of BSI. PELOD-2 score was not sensitive for clinical effects of delayed antimicrobial treatment.
IMPACT
CONCLUSIONS
In critically ill children with bloodstream infections, there was no significant change in organ dysfunction as measured by PELOD-2 scores between patients who received adequate antimicrobial therapy within 3 h of their initial positive blood culture and those who started after 3 h. Higher PELOD-2 scores on day 1 were associated with larger differences in PELOD-2 scores between days 1 and 5 from index positive blood cultures. Further study is required to determine if PELOD-2 or alternative measures of organ dysfunction could be used as primary outcome measures in trials of antimicrobial interventions in pediatric critical care research.
Identifiants
pubmed: 37845523
doi: 10.1038/s41390-023-02836-3
pii: 10.1038/s41390-023-02836-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Références
Gray, J., Gossain, S. & Morris, K. Three-year survey of bacteremia and fungemia in a pediatric intensive care unit. Pediatr. Infect. Dis. J. 20, 416–421 (2001).
doi: 10.1097/00006454-200104000-00009
pubmed: 11332667
Kumar, A. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34, 1589–1596 (2006).
doi: 10.1097/01.CCM.0000217961.75225.E9
pubmed: 16625125
Weiss, S. L. et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit. Care Med. 42, 2409–2417 (2014).
doi: 10.1097/CCM.0000000000000509
pubmed: 25148597
pmcid: 4213742
Seymour, C. W. et al. Time to treatment and mortality during mandated emergency care for sepsis. N. Engl. J. Med. 376, 2235–2244 (2017).
doi: 10.1056/NEJMoa1703058
pubmed: 28528569
pmcid: 5538258
Peltan, I. D. et al. ED door-to-antibiotic time and long-term mortality in sepsis. Chest 155, 938–946 (2019).
doi: 10.1016/j.chest.2019.02.008
pubmed: 30779916
pmcid: 6533450
Liu, V. X. et al. The timing of early antibiotics and hospital mortality in sepsis. Am. J. Respir. Crit. Care Med. 196, 856–863 (2017).
doi: 10.1164/rccm.201609-1848OC
pubmed: 28345952
pmcid: 5649973
Evans, I. V. R. et al. Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis. JAMA 320, 358–367 (2018).
doi: 10.1001/jama.2018.9071
pubmed: 30043064
pmcid: 6500448
Burns, J. P., Sellers, D. E., Meyer, E. C., Lewis-Newby, M. & Truog, R. D. Epidemiology of death in the PICU at five U.S. teaching hospitals. Crit. Care Med. 42, 2101–2108 (2014).
doi: 10.1097/CCM.0000000000000498
pubmed: 24979486
pmcid: 4134743
Pollack, M. M. et al. Simultaneous prediction of new morbidity, mortality, and survival without new morbidity from pediatric intensive care: a new paradigm for outcomes assessment. Crit. Care Med. 43, 1699–1709 (2015).
doi: 10.1097/CCM.0000000000001081
pubmed: 25985385
pmcid: 4657566
Pong, S. et al. Antimicrobial treatment duration for uncomplicated bloodstream infections in critically ill children: a multicentre observational study. BMC Pediatr. 22, 179 (2022).
doi: 10.1186/s12887-022-03219-z
pubmed: 35382774
pmcid: 8981828
Proulx, F., Fayon, M., Farrell, C. A., Lacroix, J. & Gauthier, M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 109, 1033–1037 (1996).
doi: 10.1378/chest.109.4.1033
pubmed: 8635327
Leclerc, F. et al. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am. J. Respir. Crit. Care Med. 171, 348–353 (2005).
doi: 10.1164/rccm.200405-630OC
pubmed: 15516535
Leteurtre, S. et al. PELOD-2: an update of the PEdiatric logistic organ dysfunction score. Crit. Care Med. 41, 1761–1773 (2013).
doi: 10.1097/CCM.0b013e31828a2bbd
pubmed: 23685639
Karam, O. et al. Performance of the PEdiatric Logistic Organ Dysfunction-2 score in critically ill children requiring plasma transfusions. Ann. Intensive Care 6, 98 (2016).
doi: 10.1186/s13613-016-0197-6
pubmed: 27714707
pmcid: 5053948
Leteurtre, S. et al. Daily estimation of the severity of organ dysfunctions in critically ill children by using the PELOD-2 score. Crit. Care 19, 324 (2015).
doi: 10.1186/s13054-015-1054-y
pubmed: 26369662
pmcid: 4570178
National Healthcare Safety Network. National Healthcare Safety Network (NHSN) patient safety component manual. https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf (2022).
Pollack, M. M. et al. The Pediatric Risk of Mortality Score: update 2015. Pediatr. Crit. Care Med. 17, 2–9 (2016).
doi: 10.1097/PCC.0000000000000558
pubmed: 26492059
pmcid: 5048467
Allan, V. et al. Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants. J. Comp. Eff. Res. 9, 603–614 (2020).
doi: 10.2217/cer-2020-0013
pubmed: 32186922
Desai, R. J. & Franklin, J. M. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ 367, l5657 (2019).
doi: 10.1136/bmj.l5657
pubmed: 31645336
Austin, P. C. & Stuart, E. A. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat. Med. 34, 3661–3679 (2015).
doi: 10.1002/sim.6607
pubmed: 26238958
pmcid: 4626409
Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar. Behav. Res. 46, 399–424 (2011).
doi: 10.1080/00273171.2011.568786
Austin, P. C. A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality. Multivar. Behav. Res. 46, 119–151 (2011).
doi: 10.1080/00273171.2011.540480
DeMets, D. L., Psaty, B. M. & Fleming, T. R. When can intermediate outcomes be used as surrogate outcomes. JAMA 323, 1184–1185 (2020).
doi: 10.1001/jama.2020.1176
pubmed: 32105291
Prentice, R. L. Surrogate endpoints in clinical trials: definition and operational criteria. Stat. Med. 8, 431–440 (1989).
doi: 10.1002/sim.4780080407
pubmed: 2727467
Weiss, S. L. et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr. Crit. Care Med. 21, e52–e106 (2020).
doi: 10.1097/PCC.0000000000002198
pubmed: 32032273
Usher, M. G. et al. Patient heterogeneity and the J-curve relationship between time-to-antibiotics and the outcomes of patients admitted with bacterial infection. Crit. Care Med. 50, 799–809 (2022).
doi: 10.1097/CCM.0000000000005429
pubmed: 34974496
Lin, J. C. et al. New or progressive multiple organ dysfunction syndrome in pediatric severe sepsis: a sepsis phenotype with higher morbidity and mortality. Pediatr. Crit. Care Med. 18, 8–16 (2017).
doi: 10.1097/PCC.0000000000000978
pubmed: 28060151
pmcid: 7261134
Zimmerman, J. J. et al. Critical illness factors associated with long-term mortality and health-related quality of life morbidity following community-acquired pediatric septic shock. Crit. Care Med. 48, 319–328 (2020).
doi: 10.1097/CCM.0000000000004122
pubmed: 32058369
pmcid: 7089387